fda bpc-157 status 2026 Legal Status: Regulations and Compounding FDA's own advisory committee voted

FDA's own advisory committee voted 8 6 Thursday. BPC 157, on the compounding list now, for ulcerative colitis. FDA staff argued against it, laid out the data gaps, the whole case. Panel overruled them FDA panel backs compounded BPC 157, KPV peptides in win for RFK Jr. STAT Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA reviewers urge 'no' on BPC 157, TB 500, MOTS c ahead of July 2026 compounding vote PeptideKnow

SKU: 34020284867 · From clintoncounty708.com